Heart failure trials in Italy
103 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 November 2026. Ask the study team whether a trial fits you.
- Phase 2Not yet taking people in ItalyA Study of Bimagrumab in Participants With HFpEF
- Where
- Caserta, Torino
- Age
- 18 years and over
- People
- 540 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07920887 · EU 2026-527983-34-00 - No phaseTaking peopleTrial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- Where
- Turin
- Age
- 18 years and over
- People
- 850 worldwide
- Run by
- Abbott Medical Devices
See details and how to joinNCT06526195 - No phaseTaking peopleProduct Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- Where
- Ancona, Bari, Bergamo, Bologna, Brescia, Castrovillari, Cotignola, Lecce, Milan, Monza, Pisa, Taranto, Udine
- People
- 20,000 worldwide
- Run by
- Medtronic
See details and how to joinNCT00271180 - No phaseTaking peopleHeart Failure and Aortic Stenosis Transcriptome
- Where
- Milan, San Donato Milanese
- Age
- 40 years to 75 years
- People
- 500
- Run by
- IRCCS Policlinico S. Donato
See details and how to joinNCT03268135 - Phase 3Taking peopleStudy With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
- Where
- Arzignano, Bergamo, Brescia, Ferrara, Milan, Perugia, Rimini, Rome, Sesto San Giovanni
- Age
- 18 years to 85 years
- People
- 1,800 worldwide
- Run by
- Cytokinetics
See details and how to joinNCT06736574 · EU 2024-519219-32-00 - Phase 2/3Taking peopleEfficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- Where
- Bergamo, Bologna, Florence, Genoa, Milan, Padova, Rome, Turin
- Age
- 29 days to 17 years
- People
- 342 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT05714085 · EU 2022-501238-52-00 - Phase 3Taking peopleMaridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Where
- Bari, Bergamo, Brescia, Cortona AR, Foggia, Forlì, Milan, Naples, Parma, Pavia, Rimini, Rivoli, Roma, Sassari
- Age
- 18 years to 99 years
- People
- 5,056 worldwide
- Run by
- Amgen
See details and how to joinNCT07037459 - No phaseNot yet taking people in ItalyMetabolic Changes in Heart Failure Patients Treated With Vericiguat
- Where
- Potenza
- Age
- 18 years and over
- People
- 30
- Run by
- University of Salerno
See details and how to joinNCT07901270 - Phase 3Taking peopleA Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
- Where
- Bergamo, Foggia, Genoa, Naples, Pavia, Rome, Rozzano
- Age
- 18 years and over
- People
- 6,712 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06424288 · EU 2023-509706-30-00 - Phase 3Taking peopleA Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
- Where
- Bergamo, Naples, Pavia, Pisa, Rome, Rozzano
- Age
- 18 years and over
- People
- 4,200 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06935370 · EU 2024-519525-38-00 - Phase 3Taking peopleMaridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity (MARITIME-HF)
- Where
- Bari, Bergamo, Brescia, Cortona, Foggia, Forli', Milan, Naples, Parma, Pavia, Rimini, Rivoli, Rome, Rozzano, Sassari
- Age
- 18 years and over
- People
- 2,787 worldwide
- Run by
- Amgen Inc.
See details and how to join2024-516654-22-00 · EU 2024-516654-22-00 - Phase 3Taking peopleA Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
- Where
- Bergamo, Bologna, Genoa, Milan, Naples, Padova, Rome, Turin
- Age
- Up to 18 years
- People
- 117 worldwide
- Run by
- Bayer
See details and how to joinNCT07192952 · EU 2024-519830-22-00 - No phaseTaking peopleBIO|STREAM.CSP Study
- Where
- Bergamo, Brindisi, Milan, Novara, Piove di Sacco, Roma, Taranto
- Age
- 18 years and over
- People
- 1,000 worldwide
- Run by
- Biotronik SE & Co. KG
See details and how to joinNCT07393009 - Phase 3Taking peoplePhase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- Where
- Alexandria, Bari, Bergamo, Brescia, Chiavari, Ferrara, Foggia, Milan, Monza, Naples, Novara, Orbassano, Palermo, Pavia, Potenza, Rome, Rozzano, Siena, Turin, Udine
- Age
- 40 years and over
- People
- 11,300 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06677060 · EU 2024-514506-32-00 - Phase 3Taking peopleCLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
- Where
- Ancona - Torrette, Bologna, Bolzano, Brescia, Cona, Florence, Ivrea, Lecco, Messina, Milan, Naples, Orbassano, Palermo, Pavia, Perugia, Pisa, Roma, Rome, San Donato Milanese, Trieste
- Age
- 18 years and over
- People
- 1,280 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07207811 - No phaseTaking peopleCytOSorb TreatMent Of Critically Ill PatientS Registry
- Where
- Roma, San Giovanni Rotondo
- People
- 3,000 worldwide
- Run by
- CytoSorbents, Inc
See details and how to joinNCT05146336 - No phaseTaking peopleDrug Management in Heart Failure
- Where
- Rome
- Age
- 18 years and over
- People
- 450
- Run by
- IRCCS San Raffaele Roma
See details and how to joinNCT06915584 - No phaseTaking peopleThe Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)
- Where
- Roma
- Age
- 18 years and over
- People
- 754 worldwide
- Run by
- Sunnybrook Health Sciences Centre
See details and how to joinNCT05427370 - No phaseTaking peopleEstimation of Cardiovascular Risk in Patients With Crohn's Disease and Ulcerative Colitis (PROVACI)
- Where
- San Donato Milanese
- Age
- 16 years and over
- People
- 600
- Run by
- IRCCS Policlinico S. Donato
See details and how to joinNCT07095634 - Phase 4Taking peoplePharmacological Optimization in Prevention in Heart Failure: A Sex-gap?
- Where
- Ancona, Cecina, Ferrara, Florence, Milan, Pisa, Ravenna, Reggio Emilia, Roma, San Donato Milanese
- Age
- 18 years to 85 years
- People
- 368
- Run by
- IRCCS Policlinico S. Donato
See details and how to joinNCT07295522 - Phase 3Taking peopleA Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
- Where
- Bergamo, Bologna, Genoa, Milan, Naples, Padova, Rome, Turin
- Age
- 6 months to 17 years
- People
- 111 worldwide
- Run by
- Bayer
See details and how to joinNCT07188805 · EU 2024-519829-38-00 - Phase 3Taking peopleStudy to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- Where
- Acquaviva delle Fonti, Bari, Bergamo, Brescia, Catania, Catanzaro, Cona, Cortona, Florence, Milan, Novara, Pavia, San Giovanni Rotondo
- Age
- 18 years to 130 years
- People
- 3,850 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06307652 · EU 2023-508162-15-00 - No phaseTaking peopleFluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)
- Where
- Ancona, Bergamo, Milan
- Age
- 22 years and over
- People
- 400 worldwide
- Run by
- Reprieve Cardiovascular, Inc
See details and how to joinNCT06898515 - No phaseTaking peopleArtificial Voice Analysis and Telemonitoring for Heart Failure. A Feasibility Study
- Where
- Milan
- Age
- 18 years and over
- People
- 60
- Run by
- Niguarda Hospital
See details and how to joinNCT07664748 - No phaseTaking peopleA Study to Learn About the Use of Acoramidis in Patients With a Heart Condition Called Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in a Real-world Setting
- Where
- Multiple Locations
- Age
- 18 years and over
- People
- 2,000 worldwide
- Run by
- Bayer
See details and how to joinNCT07235462